Open original FDA record ↗Recall record
- FDA identifier
- Z-2622-2024
- Company in FDA record
- DRG International, Inc.
- FDA classification date
- Aug 15, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class III
Reason stated in the source
Invalid Controls. The Low Control is out of range; too high which causes invalid runs that would result in repeating the runs and delays for reporting results to patients.
Source facts
- Action
- On July 8, 2024 Urgent Field Safety Notification letters were sent to customers. Action to be taken by Distributors and End-users: Please check your inventory for the respective lots 66K014 and 66K123. and stop using these kits immediately and promptly quarantine them. If you faced this issue of failed controls, kindly report with daya, and request a replacement for the kits used that were affected. Also, all unused kits still in your stock of the affected lot(s) will also be replaced. Immediately reply to email: qa@drg-international.com to confirm this notice and your compliance. Please indicate in the email the quantity of kits used which failed and quantity of stock remaining. We sincerely apologize for the inconvenience this may have caused you and/or your customer(s).
- Initiated
- 2024-07-05
- Root cause
- Nonconforming Material/Component
- Distribution
- US Nationwide distribution in the states of CA, IL, MN, PA, UT, VA.
- Recall number
- Z-2622-2024
- Recall status
- Open, Classified
- CDRH record ID
- 209117
- FDA classified
- 2024-08-15
- Recall event number
- 95021